INTEGRATE |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | -.--% |
| 6 months | -99.00% |
3 years
0.00
0.13
5 years
0.000.13
| Managers | Title | Age | Since |
|---|---|---|---|
Brad Nightingale
PSD | President | 54 | - |
Luke Zouvas
PRN | Corporate Officer/Principal | - | - |
Integrated Pharmaceuticals, Inc. is a development-stage company. As of June 30, 2008, the Company is engaged in the development of clinically active pharmaceutical compounds, including active small molecules and recombinant deoxyribonucleic acid (DNA) technology derived products.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 0 | |
| +19.62% | 43.78B | |
| +20.44% | 21.89B | |
| +9.87% | 14.45B | |
| +13.07% | 13.63B | |
| +37.46% | 11.49B | |
| -8.59% | 6.85B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.35% | 5.06B |
- Stock Market
- Equities
- INTP Stock
